相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Advances in Virtual Screening for Cholinesterase Inhibitors
Jared A. Miles et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31-35) and Aβ(25-35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations
Wojciech Chrobak et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces A beta(40) Levels in 12-Month-Old Male A beta PPswe/PS1 Delta E9 Transgenic Mice
Georgia Watt et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues
Alireza Majdi et al.
REVIEWS IN THE NEUROSCIENCES (2020)
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease
Han Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase
Jana Marikova et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Synthesis of furocoumarin-stilbene hybrids as potential multifunctional drugs against multiple biochemical targets associated with Alzheimer's disease
Emmanuel N. Agbo et al.
BIOORGANIC CHEMISTRY (2020)
Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor
Qi Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors
Ziwen Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review
R. Cooray et al.
MOLECULAR NEUROBIOLOGY (2020)
Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity
Laura Casares et al.
REDOX BIOLOGY (2020)
Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening
Jared A. Miles et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors
Anze Meden et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors
Satish N. Dighe et al.
ACS OMEGA (2020)
Looking beyond the standard version of the Morris water task in the assessment of mouse models of cognitive deficits
Jogender Mehla et al.
HIPPOCAMPUS (2019)
Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient
Raju Dash et al.
JOURNAL OF MOLECULAR MODELING (2019)
Δ8-Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence
Zheng-Xiong Xi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease
Mingfei Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Novel pyridazinone derivatives as butyrylcholinesterase inhibitors
Yasemin Dundar et al.
BIOORGANIC CHEMISTRY (2019)
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors
Jesus M. Roldan-Pena et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies
Yingying Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model
Matthias Hoffmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation
Soroor Sadegh Malvajerd et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease
Peterson de Andrade et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors
Lanlan Jing et al.
DRUG DISCOVERY TODAY (2019)
Low-dose bisphenol A exposure impairs learning and memory ability with alterations of neuromorphology and neurotransmitters in rats
Haibin Zhang et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2019)
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity
Urban Kosak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids
Federica Pollastro et al.
JOURNAL OF NATURAL PRODUCTS (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease
Sara Mostafavi et al.
NATURE NEUROSCIENCE (2018)
Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia
Tavia E. Evans et al.
NEUROIMAGE (2018)
Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
Sarka Pospisilova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Progressive impairment of directional and spatially precise trajectories by TgF344-Alzheimer's disease rats in the Morris Water Task
Laura E. Berkowitz et al.
SCIENTIFIC REPORTS (2018)
Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors
Guo-Liang Qiu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Novel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity
Bo Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors
Marcela Vettorazzi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease
Anushka C. Galasiti Kankanamalage et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Proline-Based Carbamates as Cholinesterase Inhibitors
Hana Pizova et al.
MOLECULES (2017)
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode
Edgar Sawatzky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents
Serena Montanari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening
Satish N. Dighe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Recent Knowledge on Medicinal Plants as Source of Cholinesterase Inhibitors for the Treatment of Dementia
Rosa Tundis et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Does cannabidiol have a role in the treatment of schizophrenia?
Anand Gururajan et al.
SCHIZOPHRENIA RESEARCH (2016)
Synthesis and antimycobacterial properties of ring-substituted 6-hydroxynaphthalene-2-carboxanilides
Jiri Kos et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Design and synthesis of celastrol derivatives as anticancer agents
Wen-Jian Tang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Organic Carbamates in Drug Design and Medicinal Chemistry
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide
Bret D. Freudenthal et al.
NATURE (2015)
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1aΔE9 mice
David Cheng et al.
PSYCHOPHARMACOLOGY (2014)
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease
Peter T. Nelson et al.
ACTA NEUROPATHOLOGICA (2013)
Azone analogues: classification, design, and transdermal penetration principles
Josef Jampilek et al.
MEDICINAL RESEARCH REVIEWS (2012)
Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort
E. Manrique-Garcia et al.
PSYCHOLOGICAL MEDICINE (2012)
Photosynthesis-Inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates
Ales Imramovsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Cannabis use at a young age is associated with psychotic experiences
C. D. Schubart et al.
PSYCHOLOGICAL MEDICINE (2011)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Comparison of Blood-Brain Barrier Permeability Assays: In Situ Brain Perfusion, MDR1-MDCKII and PAMPA-BBB
Li Di et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental alzheimer therapeutic, dihydrobenzodioxepine cymserine
Mohammad A. Kamal et al.
NEUROCHEMICAL RESEARCH (2008)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine
P Bar-On et al.
BIOCHEMISTRY (2002)
分享论文
